Further, in glioblastomas with activating mutation in EGFR, NF-κB is activated through mTORC2 in an SGK1-dependent manner that does not require Akt or mTORC1, underlying the Akt-independence of this pathway [40]. The gene discussed is NFKB1; the disease is glioblastoma.